MentalHealthDaily

At-Home tDCS Trial (HomeDC) Prematurely Terminated Due to Skin Lesions & Safety Concerns (2023 Study)

Transcranial Direct Current Stimulation (tDCS) is emerging as a promising home-based treatment for Major Depressive Disorder (MDD), offering a non-invasive, cost-effective, and scalable option for patients. This treatment modulates cortical excitability, potentially altering neuronal activity in the brain areas associated with depression. However, a recent randomized controlled trial (RCT), the HomeDC trial, aimed at investigating …

Cognitive Function Does Not Predict Response to tDCS for Depression (2023 Trial)

by GLOOM

Transcranial Direct Current Stimulation (tDCS) has been explored as a potential treatment for major depressive disorder (MDD), particularly for patients who have not responded to traditional treatments like selective serotonin reuptake inhibitors (SSRIs). This non-invasive technique involves applying a weak electrical current to the prefrontal cortex of the brain, aiming to modulate neurocognitive functions. However, …

Tramadol for Depression: Highly Effective as Off-Label Antidepressant (According to User Reviews)

by GLOOM

Tramadol, commonly known for its pain-relieving properties, has emerged as an effective off-label treatment for depression according to patient experiences and reviews. A recent analysis of tramadol’s antidepressant potential examined user feedback – comparing its efficacy and safety with established antidepressants. It considered the perspectives of patients who have found relief from depression with tramadol, …

tDCS for Fibromyalgia: Efficacy of Transcranial Direct Current Stimulation (2024 Review)

by GLOOM

A recent systematic review and meta-analysis aimed to update the understanding of the efficacy and safety of transcranial direct current stimulation (tDCS) for treating fibromyalgia (FM), focusing on its effects on analgesia, antidepressant outcomes, and the reduction of FM’s impact. Highlights: Efficacy of tDCS: The analysis revealed that tDCS is effective in reducing pain intensity, …

Xylopic Acid for Depression: May Increase Efficacy of Select Antidepressants via Synergistic Effect (2024 Study)

by GLOOM

In a new study, researchers discovered the synergistic antidepressant-like effects of xylopic acid (XA), a natural compound extracted from the dried fruits of Xylopia aethiopica, when combined with conventional antidepressants in mice. The study meticulously explored the interaction between XA and antidepressants like fluoxetine, sertraline, imipramine, and ketamine, revealing a promising potential for enhancing antidepressant …

Bergen 4-Day Treatment (B4DT) Appears Effective for OCD in Adolescents (2024 Study)

by GLOOM

Obsessive-Compulsive Disorder (OCD) in adolescents is a challenging condition, marked by intrusive thoughts and compulsive behaviors that significantly impair daily functioning. Recent studies have spotlighted the Bergen 4-Day Treatment (B4DT), an intensive, concentrated therapy approach showing promising outcomes in treating adolescents with OCD across various sites in Norway. This innovative method, comprising prolonged sessions of …

tDCS for Insomnia & Sleep Disturbances: Targeting the Infralimbic Cortex to Ventrolateral Preoptic Area Pathway (2024 Study)

by GLOOM

In the quest to effectively treat insomnia, a condition plaguing millions worldwide, scientists are exploring innovative treatments beyond traditional medication. Transcranial Direct Current Stimulation (tDCS) emerges as a promising intervention, offering a non-invasive method to modulate brain activity and enhance sleep quality. A recent study suggests tDCS may treat stress-related sleep disturbances and highlights the …